Press-release for stocks

Prices are updated after-hours

crawled date : 2021 - 11 - 11 source : Www.biospace.com

save search

Acutus Medical Reports Third Quarter 2021 Financial Results
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
AFIB | $0.169 0.06% 0.06% 47K

Health Technology

| -97.7% | O: -0.27% H: 1.22% C: -9.63%
financial results results

Study Shows Guardant360® Liquid Biopsy Test Helps Guide Treatment for Patients with HER2-Driven Metastatic Colorectal Cancer
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M

Health Services

| -82.56% | O: 0.18% H: 1.32% C: 1.27%
treatment test cancer colorectal cancer her2+ her2- her2

BioLife Solutions Announces Third Quarter 2021 Financial Results
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
BLFS S | $17.165 0.85% 0.84% 520K

Health Technology

| -65.35% | O: 0.67% H: 0.0% C: -2.28%
financial results results

Fusion Pharmaceuticals To Present At The 2021 Jefferies London Healthcare Conference
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
FUSN | $21.4 -0.09% -0.09% 270K

Health Technology

| 219.4% | O: 1.2% H: 2.8% C: -1.92%
conference

Opiant Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
EBS | News | $2.18 -4.8% 0.0% 800K

Health Technology

| -93.79% | O: -0.31% H: 2.6% C: 1.29%
OPNT | $20.65 -0.58% 0.48% 0

Health Technology

| -26.03% | O: 0.78% H: 0.42% C: 0.42%
financial results results

Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Third Quarter 2021 Financial Results
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
AVIR | $3.705 -0.67% -0.67% 200K

Health Technology

| -65.32% | O: 0.24% H: 2.21% C: -0.52%
financial results results

Onconova Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business UpdateConference call and live webcast at 4:30 p.m. ET today
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
ONTX | $0.9953 -5.61% 1.3M

Health Technology

| -70.5% | O: 0.88% H: 2.63% C: 2.05%
financial results results oda conference

Co-Diagnostics Reports Continued Strength in Third Quarter 2021 Financial Results
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
CODX | $1.17 1.74% 1.71% 33K

Health Technology

| -86.81% | O: 0.0% H: 0.93% C: 0.12%
financial results results diagnostics diagnostic

Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
RLMD | $3.85 -1.54% -1.56% 110K

Health Technology

| -84.47% | O: -0.32% H: 3.67% C: 3.55%
financial results results

NovaBay Pharmaceuticals Reports Third Quarter 2021 Financial Results
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
NBY | $0.0773 0.39% 0.0% 920K

Health Technology

| -85.71% | O: -0.07% H: 0.0% C: -1.61%
financial results results

Movano Inc. Provides Business Update and Reports Third Quarter 2021 Financial Results
Published: 2021-11-11 (Crawled : 22:00) - biospace.com/
MOVE | $0.476 -1.67% -1.7% 10K

Manufacturing

| -85.16% | O: 0.89% H: 4.12% C: 2.06%
financial results results

AXIS RESEARCH & TECHNOLOGIES OPENS IN NASHVILLE
Published: 2021-11-11 (Crawled : 22:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -95.76% | O: 6.01% H: 0.0% C: 0.0%
research nash technology

Eisai Presents New Analysis Of Lecanemab Clinical Efficacy Results From Phase 2b Study At Clinical Trials On Alzheimer's Disease (CTAD) Conference
Published: 2021-11-11 (Crawled : 20:00) - biospace.com/
BIIB | $201.91 4.52% 4.32% 3.3M

Health Technology

| -24.33% | O: -0.12% H: 0.37% C: -0.02%
disease alzheimer ema phase 2 clinical trials results trials phase 2b trial conference alzheimer’s alzheimer's disease alzheimer's lecanemab

TRACON Pharmaceuticals to Present at the Jefferies London Virtual Healthcare Conference
Published: 2021-11-11 (Crawled : 17:00) - biospace.com/
TCON | $1.895 2.43% 2.37% 65K

Health Technology

| -43.58% | O: 0.0% H: 2.09% C: -0.9%
conference

ABVC Biopharma Receives Additional $4,245,000 from Exercise of Warrants, Total Capital from Public Offering Increases to Approx. $11.1M
Published: 2021-11-11 (Crawled : 17:00) - biospace.com/
ABVC | $1.475 9.26% 8.47% 6.3M

Wholesale Trade

| -55.02% | O: 5.78% H: 0.86% C: -1.72%
offering biopharma

electroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum
Published: 2021-11-11 (Crawled : 16:00) - biospace.com/
ECOR | $5.98 5.65% 5.35% 4.9K

Health Technology

| 503.31% | O: 2.71% H: 0.93% C: -1.79%
diagnostics diagnostic

Organon Reports Results for the Third Quarter Ended September 30, 2021
Published: 2021-11-11 (Crawled : 16:00) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M

Health Technology

| 51.17% | O: -0.11% H: 0.41% C: 0.12%
results

Vericel to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on November 18th, 2021
Published: 2021-11-11 (Crawled : 16:00) - biospace.com/
VCEL | $46.09 -0.71% -0.72% 200K

Health Technology

| 10.0% | O: 0.55% H: 2.42% C: 1.02%
MDWD | $17.54 6.89% 6.44% 48K

Health Technology

| 441.23% | O: 0.0% H: 3.38% C: -1.85%
diagnostics diagnostic

Finch Therapeutics to Participate in Upcoming Investor Conferences
Published: 2021-11-11 (Crawled : 16:00) - biospace.com/
FNCH | $2.305 -17.35% -20.99% 120K

Professional, Scientific, and T...

| -84.07% | O: 1.25% H: 5.95% C: 4.31%
conference therapeutics

Longboard Pharmaceuticals to Participate in Upcoming Investor Conferences
Published: 2021-11-11 (Crawled : 16:00) - biospace.com/
LBPH | $19.76 -2.52% -2.58% 300K

Manufacturing

| 214.99% | O: 0.64% H: 0.0% C: -1.74%
conference